Bristol Myers Squibb Co. | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

12,890 results for “Bristol Myers Squibb Co.”

Trials

View all 2782 →

Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH & Co. KGaA, Germany), in Healthy Volunteers Under Fasting Conditions

36 participants · First posted Jan 10, 2019

Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer

12 participants · First posted Nov 30, 2011

Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes

100 participants · First posted Oct 22, 2015

Drugs

View all 1115 →

CK1 alpha degrader

anti-CD19 human antibodies

BMS-986218

Organizations

View all 1558 →

Bristol-Myers Squibb GmbH & Co. KGaA

Germany

Bristol-Myers Squibb Company

United States

BRISTOL MYERS SQUIBB

United States

News

View all 7435 →

Syngene International Extends Strategic Bristol Myers Squibb Collaboration Through 2035

Paradigm and Bristol Myers Squibb Collaborate to Enhance Clinical Trial Access and Efficiency

Immunocore and Bristol Myers Squibb Collaborate on Phase 3 Trial for Advanced Cutaneous Melanoma

Page 1 of 1289